High fat diets elevate adipose tissue-derived tumor necrosis factor-alpha activity

被引:69
作者
Morin, CL
Eckel, RH
Marcel, T
Pagliassotti, MJ
机构
[1] UNIV COLORADO, HLTH SCI CTR, DIV ENDOCRINOL DIABET & METAB, DEPT PEDIAT, DENVER, CO 80262 USA
[2] UNIV COLORADO, HLTH SCI CTR, DIV ENDOCRINOL DIABET & METAB, CTR HUMAN NUTR, DENVER, CO 80262 USA
关键词
D O I
10.1210/en.138.11.4665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue-derived tumor necrosis factor-a (AT-TNF) has been associated with genetic models of insulin resistance and obesity. It is presently unknown if secreted AT-TNF protein is bioactive or whether it can be increased by environmentally induced obesity. In this study, male Wistar rats were fed either a low fat (LF; 12% of energy from corn oil) or a high fat (HF; 45% of energy from corn oil) diet for 5 weeks. From previous data, it is known that after 3 weeks, HF fed animals are obese and insulin resistant compared with the LF group. Hence, animals were killed at 1 week of HF feeding, during the acute response to the diet, and at 5 weeks, when differences in body fat are manifest. Weight gain was significantly increased by diet (P = 0.03) and time (P < 0.0001). AT-TNF bioactivity was measured on secreted protein collected from medium of minced, incubated epididymal(EPI), mesenteric (MES), and retroperitoneal (RETRO) fat pads. AT-TNF bioactivity was significantly increased by diet (P = 0.003) in the RETRO pad and tended to increase (P = 0.07) in EPI. AT-TNF activity was unaffected by diet or time in the MES pad. In the RETRO pad, TNF activity correlated negatively with RETRO fat cell number (r = -0.46, P = 0.002). Secreted AT-TNF protein did not correlate with AT-TNF activity but instead decreased in RETRO with time but not diet. In EPI, secreted AT-TNF protein decreased with the HF diet. Thus, these data suggest that high fat diets and obesity can influence AT-TNF bioactivity and secretion but in an apparent fat pad-specific manner.
引用
收藏
页码:4665 / 4671
页数:7
相关论文
共 25 条
[11]  
Huizinga TWJ, 1996, J RHEUMATOL, V23, P416
[12]  
KADISH AH, 1968, CLIN CHEM, V14, P116
[13]   THE EXPRESSION OF TUMOR-NECROSIS-FACTOR IN HUMAN ADIPOSE-TISSUE - REGULATION BY OBESITY, WEIGHT-LOSS, AND RELATIONSHIP TO LIPOPROTEIN-LIPASE [J].
KERN, PA ;
SAGHIZADEH, M ;
ONG, JM ;
BOSCH, RJ ;
DEEM, R ;
SIMSOLO, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2111-2119
[14]   BETA-ADRENERGIC-BLOCKADE ATTENUATES INSULIN RESISTANCE INDUCED BY TUMOR-NECROSIS-FACTOR [J].
LANG, CH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :R984-R991
[15]  
LEIBEL RL, 1989, ANNU REV NUTR, V9, P417, DOI 10.1146/annurev.nu.09.070189.002221
[16]   Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat [J].
LopezSoriano, FJ ;
Bagby, GJ ;
Williamson, DH ;
Argiles, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (04) :E656-E660
[17]  
MALEJCZYK J, 1992, J IMMUNOL, V149, P2702
[18]  
MORIN CL, 1997, DIABETES, V46, pA252
[19]   Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM [J].
Ofei, F ;
Hurel, S ;
Newkirk, J ;
Sopwith, M ;
Taylor, R .
DIABETES, 1996, 45 (07) :881-885
[20]   TUMOR-NECROSIS-FACTOR-ALPHA PREVENTS THE DIFFERENTIATION OF HUMAN ADIPOCYTE PRECURSOR CELLS AND CAUSES DELIPIDATION OF NEWLY DEVELOPED FAT-CELLS [J].
PETRUSCHKE, T ;
HAUNER, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :742-747